Cargando…
p21(WAF1 )expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells
BACKGROUND: p21(WAF1), implicated in the cell cycle control of both normal and malignant cells, can be induced by p53-dependent and independent mechanisms. In some cells, MEKs/ERKs regulate p21(WAF1 )transcriptionally, while in others they also affect the post-transcriptional processes. In myogenic...
Autores principales: | Ciccarelli, Carmela, Marampon, Francesco, Scoglio, Arianna, Mauro, Annunziata, Giacinti, Cristina, De Cesaris, Paola, Zani, Bianca M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1343585/ https://www.ncbi.nlm.nih.gov/pubmed/16351709 http://dx.doi.org/10.1186/1476-4598-4-41 |
Ejemplares similares
-
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
por: Marampon, Francesco, et al.
Publicado: (2006) -
Anti-oncogenic and pro-myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma
por: Di Rocco, Agnese, et al.
Publicado: (2022) -
Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation
por: Marampon, Francesco, et al.
Publicado: (2019) -
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
por: Ciccarelli, Carmela, et al.
Publicado: (2016) -
Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
por: Avery, Thomas Yul, et al.
Publicado: (2022)